Copyright
©The Author(s) 2023.
World J Gastroenterol. Jan 21, 2023; 29(3): 561-578
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.561
Published online Jan 21, 2023. doi: 10.3748/wjg.v29.i3.561
Table 1 The basic clinicopathological factors of 82 collected cases
Characteristics | Number of patients | % |
Gender | ||
Male | 55 | 67.07 |
Female | 27 | 32.93 |
Age | ||
≤ 65 | 34 | 41.46 |
> 65 | 47 | 57.32 |
NA | 1 | 1.22 |
Race | ||
North America | 35 | 42.68 |
European | 17 | 20.73 |
Asia | 26 | 31.71 |
other | 4 | 4.88 |
Year | ||
≤ 2000 | 20 | 24.39 |
> 2010 | 62 | 75.61 |
Tumor origin | ||
Primary | 62 | 75.61 |
Secondary | 14 | 17.07 |
NA | 6 | 7.32 |
Radiation history | ||
With | 21 | 25.61 |
Without | 61 | 74.39 |
Table 2 Age distribution characteristics of patients
Gender | Number | Mean age | SD | Median age | Range of age |
Female | 26 | 60.85 | 22.73 | 70 | 20-92 |
Male | 55 | 64.44 | 14.92 | 68 | 25-87 |
All | 82 | 63.28 | 17.74 | 68 | 20-92 |
Table 3 Patients’ symptoms during the disease
Symptoms | Number | Percentage (%) |
Gastrointestinal bleeding | 51 | 62.20 |
Anemia | 47 | 57.32 |
Abdominal pain | 31 | 37.80 |
Weak | 19 | 23.17 |
Loss of weight | 15 | 18.29 |
Short of breath | 13 | 15.85 |
Nausea | 11 | 13.41 |
Abdominal distention | 10 | 12.20 |
Loss of appetite | 8 | 9.76 |
Dizziness | 5 | 6.10 |
Fever | 3 | 3.66 |
Constipation | 3 | 3.66 |
Chest pain | 3 | 3.66 |
Back pain | 3 | 3.66 |
Diarrhea | 2 | 2.44 |
Syncope | 2 | 2.44 |
Drowsiness | 1 | 1.22 |
Peripheral edema | 1 | 1.22 |
Lower limb weakness | 1 | 1.22 |
Table 4 Characteristics of immunohistochemistry results
Pathological markers | Total | Positive | Negative |
CD31 | 49 | 49 | 0 |
CD34 | 40 | 30 | 10 |
Vimentin | 28 | 28 | 0 |
VIII | 29 | 26 | 3 |
ERG | 10 | 10 | 0 |
FLI-1 | 6 | 6 | 0 |
von Willebrand factor | 2 | 2 | 0 |
EMA | 17 | 1 | 16 |
SMA | 10 | 0 | 10 |
CD117 | 10 | 0 | 10 |
Desmin | 11 | 0 | 11 |
S100 | 28 | 1 | 27 |
Table 5 Location of small intestinal angiosarcoma
Tag | Location | Number | Percentage (%) |
A | Jejunum | 23 | 28.0 |
B | Ileum | 16 | 19.5 |
C | Duodenum | 10 | 12.2 |
D | Duodenum, Jejunum and Ileum | 10 | 12.2 |
E | Duodenum and Jejunum | 9 | 11.0 |
F | Jejunum and Ileum | 5 | 6.1 |
G | Unspecified small intestine | 9 | 11.0 |
Table 6 Characteristics of small intestinal angiosarcoma lesions
Characteristics | Number | % |
Size | ||
≤ 40 mm | 38 | 45.78 |
> 40 mm | 14 | 16.87 |
Diffuse | 2 | 2.41 |
NA | 29 | 34.94 |
Small intestinal lesions | ||
Single focal | 26 | 35.6 |
Multifocal | 47 | 64.4 |
NA | 9 | |
Pathological morphology | ||
Ulcerative | 13 | 15.66 |
Protuberant | 41 | 49.4 |
Superficial | 8 | 9.64 |
Diffuse infiltrating | 6 | 7.23 |
NA | 15 | 18.07 |
Infiltration depth | ||
Mucosa | 3 | 3.61 |
Submucosa | 17 | 20.48 |
Muscularis propria | 7 | 8.43 |
Serosa | 17 | 20.48 |
Under the serosa | 1 | |
NA | 39 | 46.99 |
Table 7 Distant metastatic site of primary small intestinal angiosarcoma
Distant metastasis | Number | % |
No metastasis | 23 | 37.1 |
Lung | 14 | 22.6 |
Liver | 13 | 21.0 |
Large intestine | 13 | 21.0 |
Spleen | 5 | 8.1 |
Bone | 5 | 8.1 |
Pleural | 4 | 6.5 |
Stomach | 4 | 6.5 |
Bladder | 3 | 4.8 |
Kidney | 2 | 3.2 |
Vein | 2 | 3.2 |
Abdominal wall | 2 | 3.2 |
Gallbladder | 2 | 3.2 |
Pancreas | 1 | 1.6 |
Heart | 1 | 1.6 |
Adrenal gland | 1 | 1.6 |
Pelvic cavity | 1 | 1.6 |
Brain | 1 | 1.6 |
Oropharynx | 1 | 1.6 |
Diaphragm | 1 | 1.6 |
NA | 4 | 6.5 |
All | 62 | 100% |
Table 8 Analysis of risk factors for small intestinal angiosarcoma
Gender/age (yr) | Time1 (yr) | Cause of radiation | Radiation area | Dose (Gray) |
F/66 | 20 | Uterus cancer | Pelvis | NA |
F/69 | 7 | Adenocarcinoma of uterus | Pelvis | NA |
F/50 | 14 | Adenocarcinoma of uterine body | Pelvis | 55.6 |
F/76 | 7 | Adenocarcinoma of uterine body | Pelvis | 45.1 |
F/78 | 10 | Endometrial cancer | Pelvis | 55.5 |
F/51 | 9 | Adenocarcinoma of cervix | Pelvis | 50 |
F/80 | 20 | Squamous cell carcinoma of cervix | Pelvis | 55 |
F/61 | 20 | Squamous cell carcinoma of cervix | Pelvis | NA |
F/NA | 8 | Cervical cancer | Pelvis | NA |
F/72 | 24 | Leiomyosarcoma of uterus | Pelvis | NA |
F/26 | 14 | Dysgerminoma of ovary | Pelvis | 48 |
F/66 | 8 | Ovarian cancer | Pelvis | 60 |
F/88 | 18 | Breast cancer | Chest | NA |
F/37 | NA | Breast cancer | Chest | NA |
F/92 | 12 | Colon cancer | Pelvis | NA |
M/82 | NA | Prostate cancer | Pelvis | NA |
M/80 | NA | Prostate cancer | Pelvis | NA |
M/73 | NA | Squamous cell carcinoma of tonsil | Neck | NA |
M/63 | 45 | Left lower abdominal lymphoma | Abdomen | 15 |
M/57 | 8 | Chondrosarcoma of right hemipelvis | Pelvis | NA |
M/68 | 30 | Occupational exposure | NA | Heavy |
Table 9 Results of univariate COX regression analysis
Factors | HR (98%CI) | P value |
Gender (male/female) | 1.395 (0.772-2.521) | 0.270 |
Age (> 65/≤ 65) | 1.803 (1.007-3.227) | 0.047 |
Tumor origin (secondary/primary) | 1.708 (0.789-3.696) | 0.174 |
Tumor size(> 40 mm/≤ 40 mm) | 1.265 (0.578-2.767) | 0.557 |
Tumor lesion (multifocal/single focal) | 1.365 (0.722-2.579) | 0.338 |
Distant metastases (yes/no) | 1.140 (0.573-2.269) | 0.708 |
Acute abdominal disease (yes/no) | 0.780 (0.424-1.435) | 0.424 |
Surgery (with/without) | 0.570 (0.296-1.100) | 0.094 |
Chemotherapy (with/without) | 0.473 (0.238-0.940) | 0.032 |
Gastrointestinal bleeding (yes/no) | 1.076 (0.604-1.915) | 0.803 |
Tumor distribution | ||
Two segments/one segment | 2.116 (0.975-4.593) | 0.058 |
Whole intestine/one segment | 2.473 (1.156-5.289) | 0.020 |
Table 10 Results of multivariate COX regression analysis
Factors | HR (98%CI) | P value |
Chemotherapy (with/without) | 0.442 (0.205-0.956) | 0.038 |
Surgery (with/without) | 0.407 (0.182-0.908) | 0.028 |
Age (> 65/≤ 65) | 1.944 (0.969-3.902) | 0.061 |
Tumor distribution | ||
Two segments/one segment | 0.434 (0.194-0.969) | 0.042 |
Whole intestine/one segment | 0.820 (0.323-2.086) | 0.677 |
- Citation: Ma XM, Yang BS, Yang Y, Wu GZ, Li YW, Yu X, Ma XL, Wang YP, Hou XD, Guo QH. Small intestinal angiosarcoma on clinical presentation, diagnosis, management and prognosis: A case report and review of the literature. World J Gastroenterol 2023; 29(3): 561-578
- URL: https://www.wjgnet.com/1007-9327/full/v29/i3/561.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i3.561